Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia.
Veltri G, Lovisa F, Cortese G, Pillon M, Carraro E, Cesaro S, Provenzi M, Buffardi S, Francescato S, Biffi A, Buldini B, Conter V, Serafin V, Mussolin L. Veltri G, et al. Among authors: biffi a. Front Oncol. 2022 Jul 8;12:913487. doi: 10.3389/fonc.2022.913487. eCollection 2022. Front Oncol. 2022. PMID: 35875136 Free PMC article.
Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system.
Cani A, Tretti Parenzan C, Frasson C, Rampazzo E, Scarparo P, Francescato S, Caicci F, Barbieri V, Rosato A, Cesaro S, Zecca M, Micalizzi C, Sainati L, Pigazzi M, Biffi A, Buldini B, Locatelli F, Persano L, Masetti R, Te Kronnie G, Bresolin S. Cani A, et al. Among authors: biffi a. Blood Adv. 2023 Apr 25;7(8):1513-1524. doi: 10.1182/bloodadvances.2021006746. Blood Adv. 2023. PMID: 36053787 Free PMC article.
Low miR-214-5p Expression Correlates With Aggressive Subtypes of Pediatric ALCL With Non-Common Histology.
Di Battista P, Lovisa F, Gaffo E, Gallingani I, Damanti CC, Garbin A, Ferrone L, Carraro E, Pillon M, Lo Nigro L, Mura R, Pizzi M, Guzzardo V, Dei Tos AP, Biffi A, Bortoluzzi S, Mussolin L. Di Battista P, et al. Among authors: biffi a. Front Oncol. 2021 May 25;11:663221. doi: 10.3389/fonc.2021.663221. eCollection 2021. Front Oncol. 2021. PMID: 34113568 Free PMC article.
Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients.
Veltri G, Silvestri C, Gallingani I, Sandei M, Vencato S, Lovisa F, Cortese G, Pillon M, Carraro E, Bresolin S, Biffi A, Basso G, Accordi B, Mussolin L, Serafin V. Veltri G, et al. Among authors: biffi a. Cancers (Basel). 2021 Jul 24;13(15):3724. doi: 10.3390/cancers13153724. Cancers (Basel). 2021. PMID: 34359628 Free PMC article.
Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of ex vivo treated pediatric T-cell acute lymphoblastic leukemia cells.
Kuzilková D, Bugarin C, Rejlova K, Schulz AR, Mei HE, Paganin M, Biffi A, Biondi A, Kalina T, Gaipa G. Kuzilková D, et al. Among authors: biffi a. Haematologica. 2022 Jun 1;107(6):1293-1310. doi: 10.3324/haematol.2021.278796. Haematologica. 2022. PMID: 34670357 Free PMC article.
489 results